In our study, the fact that fetuin-A levels were found to be significantly lower in the patient group with subclinical atherosclerosis compared to the group without subclinical atherosclerosis and significantly lower in stage 3 and stage 5 CKD groups compared to the healthy control group. Here, AHSG is linked to chronic kidney disease.